Page last updated: 2024-08-26

lopinavir and Hypertriglyceridemia

lopinavir has been researched along with Hypertriglyceridemia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calza, L; Chiodo, F; Manfredi, R; Pocaterra, D	1
Antela, A; Arribas, JR; Barros, C; Berenguer, J; Cepeda, C; Condes, E; Dronda, F; González-García, JJ; Miralles, P; Montes, ML; Navas, E; Peña, JM; Pérez, S; Pulido, F; Rubio, R; Sanz, J; Vázquez, JJ; Zapata, A	1
Antoniou, T; Giguere, P; Phillips, EJ; Tseng, AL; van Heeswijk, RP; Walker, SE	1
Antinori, A; Bongiovanni, M; Cauda, R; Ciardi, M; Cicconi, P; Cozzi-Lepri, A; De Luca, A; Di Giambenedetto, S; Grisorio, B; Marconi, P; Monforte, Ad; Resta, F; Zaccarelli, M	1
Aouadi, M; Binétruy, B; Cardot-Leccia, N; Dellamonica, P; Durant, J; Garraffo, R; Heripret, L; Lavrut, T; Le Marchand-Brustel, Y; Perrin, C; Prot, M	1
Cosín, J; Domingo, P; Galindo, MJ; García Alcalde, ML; Garrido, M; Geijo, P; Gonzalez, J; Lacalle, JR; Lopez-Aldeguer, J; Lozano, F; Muñoz, A; Ribera, E; Roca, B; Sanchez, T; Suárez-Lozano, I; Teira, R; Terrón, A; Torres, F; Vergara, A; Viciana, P; Vidal, F	1

Trials

4 trial(s) available for lopinavir and Hypertriglyceridemia

Article	Year
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. International journal of STD & AIDS, 2008, Volume: 19, Issue:8 Topics: Adult; Anti-HIV Agents; Carbamates; Diarrhea; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Furans; HIV Infections; HIV Protease; HIV-1; Humans; Hypertriglyceridemia; Lopinavir; Male; Middle Aged; Organophosphates; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides; Treatment Failure; Treatment Outcome	2008
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors. The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:5 Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Cholesterol, LDL; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Lipids; Lopinavir; Male; Middle Aged; Pyrimidinones; Risk Factors; Ritonavir; Triglycerides	2005
Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients. Therapeutic drug monitoring, 2005, Volume: 27, Issue:6 Topics: Adult; Area Under Curve; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertriglyceridemia; Indinavir; Lopinavir; Male; Metabolic Clearance Rate; Pyrimidinones	2005
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Hypertriglyceridemia; Kaplan-Meier Estimate; Longitudinal Studies; Lopinavir; Male; Pyrimidinones; Retrospective Studies; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Withholding Treatment	2008

Other Studies

2 other study(ies) available for lopinavir and Hypertriglyceridemia

Article	Year
Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison. Antiviral therapy, 2006, Volume: 11, Issue:5 Topics: Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypertriglyceridemia; Italy; Lopinavir; Male; Middle Aged; Nucleosides; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Failure; Viral Load	2006
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Adipose Tissue; Animals; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; HIV Protease Inhibitors; Hypertriglyceridemia; Lopinavir; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pyridines; Pyrimidinones; Ritonavir; RNA, Messenger; Time Factors; Triglycerides	2006

Article

Year

Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison.

Antiviral therapy, 2006, Volume: 11, Issue:5

Topics: Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypertriglyceridemia; Italy; Lopinavir; Male; Middle Aged; Nucleosides; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Failure; Viral Load

2006

Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.

Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

Topics: Adipose Tissue; Animals; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; HIV Protease Inhibitors; Hypertriglyceridemia; Lopinavir; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pyridines; Pyrimidinones; Ritonavir; RNA, Messenger; Time Factors; Triglycerides

2006